European inhaler market was valued at around $6.4 billion in 2018 and is anticipated to grow at a substantial rate of 2.3% during the forecast period. Major countries that will contribute to the inhaler market within the region includes UK, Germany, France, Italy and Spain. A significant number of companies, research, patient base has been observed in the market due to which a significant growth can be observed in the market. According to the International Monetary Fund (IMF), Europe is home to around 740 million people and the GDP of the European Union is $19.7 trillion in 2017. As per Organization for Economic Co-operation and Development (OECD), the self-reported asthma rate and COPD rate by European Union countries were 6.1% and 4.0% respectively and it has been found out that the rate of prevalence of diseases are higher in women as compared to men. This is expected to drive the regional business growth of the inhaler market.
Request a Free Sample of our Report on European Inhaler Market: https://www.omrglobal.com/request-sample/european-inhaler-market
The European inhaler market is segmented on the basis of device, type, application, and end-user. On the basis of device, the market is sub-segmented into metered dosed inhaler, dry powdered inhaler, and nebulizer. The dry powder inhaler is estimated to have largest market share in the European inhaler market due to providing easy inhalation solution. Whereas, the market for metered dose inhaler is estimated to be the fastest growing at a CAGR during the forecast period owing to innovations and collaborations by the companies for the development of metered dosed inhaler. Based on the type, preventive, reliever, and long acting bronchodilators inhaler are analyzed. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.
A full report of European Inhaler Market is available at: https://www.omrglobal.com/industry-reports/european-inhaler-market
European Inhaler Market Segmentation
By Device
• Metered Dose Inhaler
• Dry Powder Inhaler
• Nebulizer
By Type
• Preventive Inhaler
• Reliever Inhaler
• Long Acting Bronchodilators Inhaler
• European Inhaler Market by Application
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
By End-User
• Homecare
• Hospitals and Clinics
Regional Analysis
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe
Company Profiles
• 3M Co.
• Acorda Therapeutics, Inc.
• Adamis Pharmaceuticals Corp.
• Adherium Ltd.
• AstraZeneca PLC
• Bespak
• Boehringer Ingelheim International GmbH
• Chiesi Farmaceutici S.P.A.
• GF Health
• GlaxoSmithKline PLC
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-inhaler-market
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404